Advances in Research on Neurodegeneration: Vol. 10R. Horowski, Y. Mizuno, C.W. Olanow, W. Poewe, P. Riederer, J.A. Stoessel, M.B.H. Youdim Springer Science & Business Media, 24 lug 2003 - 230 pagine The 10th International Winter Conference on Neurodegeneration (lWCN) has taken place from February 14-16,2002, at the lovely "SchloB Ziethen", an old prussian manor (in Prussia, 'faute de mieux', called 'SchloB', i. e. cas tle or residence). This place is 20 km off Tegel Airport, Berlin's main airport, and has been beautifully restored by baroness Edith von Thiingen (nee von BUlow, i. e. of historical Prussian aristocracy); it lends itself rather perfectly for the IWCN type of small interdisciplinary workshops on neurodegenera tion which combine short lectures with plenty of discussion. In this context, we could quote Alexander von Humboldt's famous opening words for one of the first international scientific meetings held at Berlin, on September 18, 1828: "The main purpose . . . does not consist in a mutual reading of manuscripts all to be printed after at least one year in specialised publications, but in the personal communication amongst those who work in similar scientific fields; the oral and thus more stimulating exchange of ideas, might they represent facts, opinions or doubts; the foundation of friendly relations which convey illumination to our sciences, serene grace to our lives and tolerance and mildness to our habits . . . Berlin, Sept. 18, 1828 Alexander von Humboldt To the IWCN aficionado, it may come as a little surprise that this is the pub lication of the 10th Winter Conference as this might mean that they must have missed number 9. |
Dall'interno del libro
Risultati 1-5 di 34
Pagina 32
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Pagina 33
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Pagina 44
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Pagina 45
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Pagina 48
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Spiacenti. Il contenuto di questa pagina č ad accesso limitato..
Sommario
Possible role | 1 |
Kwidzinski E Mutlu L K Kovac A D Bunse J Goldmann J Mahlo J | 29 |
Progressive neurode | 51 |
Effect of advanced glycation endpro | 63 |
What have we learnt from cDNA microarray gene expression | 73 |
Hirsch E C Höglinger G Rousselet E Breidert T Parain K Feger J | 89 |
General aspects of neurodegeneration | 101 |
Zucca F A Costi P Tampellini D Gatti A Gerlach M Riederer | 145 |
New concepts and tools | 157 |
Arguments for the use | 167 |
The role of acetylcholine | 185 |
Growthdifferentia | 197 |
Gene therapy for Parkinsons disease | 205 |
Watts R L Raiser C D Stover N P Cornfeldt M L Schweikert A W Allen | 215 |
Altre edizioni - Visualizza tutto
Parole e frasi comuni
a-synuclein abnormal activity aggregation Agnati Alzheimer Alzheimer's disease Ann Neurol antigens apoptosis apoptotic Aẞ autoimmunity basal ganglia Bechmann Biochem Biol Brain Res cascade Caspase cell death cellular cholinergic clinical cognitive cortex cortical degeneration dementia dopamine neurons dopamine receptor dopamine receptor agonists dopaminergic neurons Drosophila dysfunction effects Exp Neurol expression factors formation free radical function gene therapy genetic glial glycation hRPE cells human immune inclusions increased induced inhibition interactions Jellinger kinase L-DOPA lesion Lewy bodies lipid lisuride mechanisms membrane memory metabolism mice microcarriers microglia mitochondrial model of Parkinson's molecular circuits motor MPTP mutant Neurochem neurodegeneration neurodegenerative diseases neurodegenerative disorders Neurology neuromelanin Neuropathol neuroprotective Neurosci neurotoxicity nigrostriatal oxidative stress Parkinson's disease parkinsonian pathogenesis pathway patients pergolide pigment pramipexole receptor mosaics release Riederer role ropinirole Spheramine striatal striatum studies substantia nigra synaptic tion tissue toxic treatment ubiquitin vivo Youdim MBH Zecca